glp-1 news september 2025 30 Repositioning GLP-1 Drugs for Neurologic Disease: Evidence, Advances, and Outlook Medscape | GLP-1 receptor agonists

This feedback loop can reinforce itself if the underlying metabolic drivers are not addressed

Specialist supervision is required, and patients should discuss potential risks and interactions with their physician before starting any GLP-1 microdosing protocol

If you have a question about an order, your care team can help

Malnutrition and Dehydration: In extreme cases, the cumulative impact of reduced food intake, frequent vomiting, and the bodys inability to absorb nutrients effectively can result in malnutrition

Ongoing clinical and mechanistic studies are expected to expand use of GLP-1 receptor agonists, glucose-dependent insulinotropic polypeptide agonists and other metabolic hormones for the treatment of chronic kidney disease